Subscribe to RSS
Lymphatic Leakage after Surgery for Neuroblastoma: A Rare Complication?
Introduction Neuroblastoma is the most common extracranial solid tumor in infancy. It is responsible for around 15% of all oncological deaths during childhood. Due to its retroperitoneal location, neuroblastoma is invasively growing directly in and around the lymphatic duct. Consecutively, lymphatic leakage (LL) after surgery for neuroblastoma is a known complication. The purpose of this study is the investigation of frequency and impact of this complication.
Material and Methods Between February 2003 and December 2016, 204 patients with neuroblastoma received surgical treatment in our department. A retrospective analysis for macroscopical extent of resection, duration of drainage postsurgery, maximum amount of fluid drained in 24 hours, MYCN amplification status, therapeutic options for LL, follow-up status, and overall survival was performed.
Results A total of 40% of patients (82/204) showed LL to some extent. In patients with MYCN amplification, LL was seen significantly more often than in patients without MYCN amplification status (p = 0.019). LL was also significantly correlated with extent of surgery (p = 0.005). Follow-up status and overall survival were significantly inversely associated with LL (p = 0.004 and p = 0.0001). LL was self-limiting in all cases. There was a trend toward shorter duration of LL if either no special therapy was chosen or total parenteral nutrition (TPN) was administered (p = 0.0603).
Conclusion We show that LL in neuroblastoma is a common complication of tumor resection and occurring more often than anticipated. Since, in our study cohort, all cases of LL were self-limiting, we question the indication for invasive therapy besides supporting measures.
Received: 08 October 2019
Accepted: 13 December 2019
20 January 2020 (online)
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet 2007; 369 (9579): 2106-2120
- 2 Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003; 3 (03) 203-216
- 3 Qureshi SS, Rent EG, Bhagat M. et al. Chyle leak following surgery for abdominal neuroblastoma. J Pediatr Surg 2016; 51 (09) 1557-1560
- 4 Weniger M, D'Haese JG, Angele MK, Kleespies A, Werner J, Hartwig W. Treatment options for chylous ascites after major abdominal surgery: a systematic review. Am J Surg 2016; 211 (01) 206-213
- 5 Weiser AC, Lindgren BW, Ritchey ML, Franco I. Chylous ascites following surgical treatment for Wilms tumor. J Urol 2003; 170 (4, Pt 2): 1667-1669
- 6 Zeidan S, Delarue A, Rome A, Roquelaure B. Fibrin glue application in the management of refractory chylous ascites in children. J Pediatr Gastroenterol Nutr 2008; 46 (04) 478-481
- 7 Lv S, Wang Q, Zhao W. et al. A review of the postoperative lymphatic leakage. Oncotarget 2017; 8 (40) 69062-69075
- 8 Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, Achen MG. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer 2014; 14 (03) 159-172
- 9 Kim EA, Park H, Jeong SG, Lee C, Lee JM, Park CT. Octreotide therapy for the management of refractory chylous ascites after a staging operation for endometrial adenocarcinoma. J Obstet Gynaecol Res 2014; 40 (02) 622-626
- 10 Cope C. Diagnosis and treatment of postoperative chyle leakage via percutaneous transabdominal catheterization of the cisterna chyli: a preliminary study. J Vasc Interv Radiol 1998; 9 (05) 727-734
- 11 Simon T, Häberle B, Hero B, von Schweinitz D, Berthold F. Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. J Clin Oncol 2013; 31 (06) 752-758
- 12 Shrikhande SV, Barreto SG, Shetty G. et al. Post-operative abdominal drainage following major upper gastrointestinal surgery: single drain versus two drains. J Cancer Res Ther 2013; 9 (02) 267-271
- 13 Berger M, Fernandez-Pineda I, Cabello R. et al. The relationship between the site of metastases and outcome in children with stage IV Wilms tumor: data from 3 European pediatric cancer institutions. J Pediatr Hematol Oncol 2013; 35 (07) 518-524
- 14 Yang C, Zhang J, Wang S, Li CC, Kong XR, Zhao Z. Successful management of chylous ascites with total parenteral nutrition and octreotide in children. Nutr Hosp 2013; 28 (06) 2124-2127
- 15 Riar S, Warshaw B, Amaral S. Chylous ascites complicating pediatric renal transplantation. Pediatr Nephrol 2012; 27 (08) 1397-1399
- 16 Huang CC, Tsai MS, Lai HS. Chylous ascites after excision of a choledochal cyst in a child. J Pediatr Surg 2009; 44 (05) e5-e7
- 17 Liu Y, Pan C, Tang JY, Chen J, Zhou M, Ye QD. What is the result: chylous leakage following extensive radical surgery of neuroblastoma. World J Pediatr 2012; 8 (02) 151-155
- 18 Chui CH. Mesenteric lymphatic ligation in the prevention of chylous fistulae in abdominal neuroblastoma surgery. Pediatr Surg Int 2014; 30 (10) 1009-1012
- 19 Hanson D, Mirkovic S. Lymphatic drainage after lumbar surgery. Spine 1998; 23 (08) 956-958
- 20 Lim C, Dokmak S, Cauchy F, Aussilhou B, Belghiti J, Sauvanet A. Selective policy of no drain after pancreaticoduodenectomy is a valid option in patients at low risk of pancreatic fistula: a case-control analysis. World J Surg 2013; 37 (05) 1021-1027
- 21 Leibovitch I, Mor Y, Golomb J, Ramon J. The diagnosis and management of postoperative chylous ascites. J Urol 2002; 167 (2, Pt 1): 449-457
- 22 Matsuda T, Fujita H, Kunimoto Y, Kimura T, Ogino K. Chylous ascites as a complication of laparoscopic colorectal surgery. Asian J Endosc Surg 2013; 6 (04) 279-284
- 23 Becker J, Pavlakovic H, Ludewig F. et al. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2. Clin Cancer Res 2010; 16 (05) 1431-1441
- 24 Van der Auwera I, Van den Eynden GG, Colpaert CG. et al. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clin Cancer Res 2005; 11 (21) 7637-7642
- 25 Ramani P, Dungwa JV, May MT. LYVE-1 upregulation and lymphatic invasion correlate with adverse prognostic factors and lymph node metastasis in neuroblastoma. Virchows Arch 2012; 460 (02) 183-191
- 26 Ribatti D, Nico B, Cimpean AM, Raica M. Podoplanin and LYVE-1 expression in lymphatic vessels of human neuroblastoma. J Neurooncol 2010; 100 (01) 151-152